Quick Links

Supported by City of Hope's NCI-funded Cancer Center Support Grant (CCSG)

 Hematologic Malignancies Program Publications, 2004

2006, 2005, 2004, 2003, 2002

Baker, K. S., Gurney, J. G., Ness, K. K., Bhatia, R., Forman, S. J., Francisco, L., McGlave, P. B., Robison, L. L., Snyder, D. S., Weisdorf, D. J., Bhatia, S. "Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. "Blood; 2004, 104(6): 1898-1906

Bethge, W. A., Hegenbart, U., Stuart, M. J., Storer, B. E., Maris, M. B., Flowers, M. E. D., Maloney, D. G., Chauncey, T., Bruno, B., Agura, E., Forman, S. J., Blume, K. G., Niederwieser, D., Storb, R., Sandmaier, B. M. "Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. "Blood; 2004, 103(3): 790-795

Chu, F. F., Esworthy, R. S., Chu, P. G., Longmate, J. A., Huycke, M. M., Wilczynski, S., Doroshow, J. H. "Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. "Cancer Research; 2004, 64(3): 962-968

Chu, P. G., Cerilli, L., Chen, Y. Y., Mills, S. E., Weiss, L. M. "Epstein-Barr virus plays no role in the tumorigenesis of small-cell carcinoma of the lung. "Modern Pathology; 2004, 17(2): 158-164

Chu, P. G., Weiss, L. M. "Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. "American Journal of Clinical Pathology; 2004, 121(6): 884-892

Chu, P. G. G., Benhattar, J., Weiss, L. M., Meagher-Villemure, K. "Intraneural synovial sarcoma: two cases. "Modern Pathology; 2004, 17(2): 258-263

Chu, S., Holtz, M., Gupta, M., Bhatia, R. "BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34(+) cells. "Blood; 2004, 103(8): 3167-3174

Cooper, L. J. N., Al-Kadhimi, Z., DiGiusto, D., Kalos, M., Colcher, D., Raubitschek, A., Forman, S. J., Jensen, M. C. "Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies. "Blood Cells Molecules and Diseases; 2004, 33(1): 83-89

Daftarian, P., Song, G. Y., Ali, S., Faynsod, M., Longmate, J., Diamond, D. J., Ellenhorn, J. D. I. "Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors. "Cancer Research; 2004, 64(15): 5407-5414

Gallez-Hawkins, G., Li, X. L., Franck, A. E., Thao, L., Lacey, S. F., Diamond, D. J., Zaia, J. A. "DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice. "Vaccine; 2004, 23(6): 819-826

Gibson, L., Piccinini, G., Lilleri, D., Revello, M. G., Wang, Z. D., Markel, S., Diamond, D. J., Luzuriaga, K. "Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8(+) T cell responses in children with congenital or postnatal human cytomegalovirus infection. "Journal of Immunology; 2004, 172(4): 2256-2264

Giles, F. J., Rodriguez, R., Weisdorf, D., Wingard, J. R., Martin, P. J., Fleming, T. R., Goldberg, S. L., Anaissie, E. J., Bolwell, B. J., Chao, N. J., Shea, T. C., Brunvand, M. M., Vaughan, W., Petersen, F., Schubert, M., Lazarus, H. M., Maziarz, R. T., Silverman, M., Beveridge, R. A., Redman, R., Pulliam, J. G., Devitt-Risse, P., Fuchs, H. J., Hurd, D. D. "A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. "Leukemia Research; 2004, 28(6): 559-565

Holtz, M. S., Bhatia, R. "Effect of Imatinib mesylate on chronic myelogenous leukemia hematopoietic progenitor cells. "Leukemia & Lymphoma; 2004, 45(2): 237-245

Huang, Q., Chang, K. L., Gaal, K. K., Weiss, L. M. "KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma. "American Journal of Surgical Pathology; 2004, 28(5): 693-697

Huang, Q., Chu, P. G., Lau, S. K., Weiss, L. M. "Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma. "Hum Pathol; 2004, 35(769-73):

Jiang, Z., Wu, C. L., Woda, B. A., Iczkowski, K. A., Chu, P. G., Tretiakova, M. S., Young, R. H., Weiss, L. M., Blute, R. D., Brendler, C. B., Krausz, T., Xu, J. C., Rock, K. L., Amin, M. B., Yang, X. J. "Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. "Histopathology; 2004, 45(3): 218-225

Kahlon, K. S., Brown, C., Cooper, L. J. N., Raubitschek, A., Forman, S. J., Jensen, M. C. "Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells. "Cancer Research; 2004, 64(24): 9160-9166

Lau, S. K., Chu, P. G., Weiss, L. M. "CD163-A specific marker of macrophages in paraffin-embedded tissue samples. "American Journal of Clinical Pathology; 2004, 122(5): 794-801

Lau, S. K., Weiss, L. M., Chu, P. G. "Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. "American Journal of Clinical Pathology; 2004, 122(1): 61-69

Openshaw, H., Beamon, K., Synold, T. W., Longmate, J., Slatkin, N. E., Doroshow, J. H., Forman, S., Margolin, K., Morgan, R., Shibata, S., Somlo, G. "Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: Lack of neuroprotective effect of amifostine. "Clinical Cancer Research; 2004, 10(2): 461-467

Parikh, C. R., Sandmaier, B. M., Storb, R. F., Blume, K. G., Sahebi, F., Maloney, D. G., Maris, M. B., Nieto, Y., Edelstein, C. L., Schrier, R. W., McSweeney, P. "Acute renal failure after nonmyeloablative hematopoietic cell transplantation. "Journal of the American Society of Nephrology; 2004, 15(7): 1868-1876

Qiu, W. H., Zhou, B. S., Zou, H. Z., Liu, X. Y., Chu, P. G. G., Lopez, R., Shih, J., Chung, C., Yen, Y. "Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. "American Journal of Pathology; 2004, 165(5): 1689-1699

Rodriguez, R., Parker, P., Nademanee, A., Smith, D., O'Donnell, M. R., Stein, A., Snyder, D. S., Fung, H. C., Krishnan, A. Y., Popplewell, L., Cohen, S., Somlo, G., Angelopoulou, M., Al-Kadhimi, Z., Falk, P. M., Spielberger, R., Kogut, N., Sahebi, F., Senitzer, D., Slovak, M., Schriber, J., Forman, S. J. "Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. "Bone Marrow Transplantation; 2004, 33(11): 1123-1129

Snyder, D. S., McMahon, R., Cohen, S. R., Slovak, M. L. "Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: Benign course responsive to imatinib with an RT-PCR advisory. "American Journal of Hematology; 2004, 75(2): 92-95

Somlo, G., Frankel, P., Chow, W., Leong, L., Margolin, K., Morgan, R., Shibata, S., Chu, P. G., Forman, S., Lim, D., Twardowski, P., Weitzel, J., Alvarnas, J., Kogut, N., Schriber, J., Fermin, E., Yen, Y., Damon, L., Doroshow, J. H. "Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose intense chemotherapy. "Journal of Clinical Oncology; 2004, 22(10): 1839-1848

Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., McCarty, J., LeMaistre, C. F., Sung, E. C., Blazar, B. R., Elhardt, D., Chen, M. G., Emmanouilides, C. "Palifermin for oral mucositis after intensive therapy for hematologic cancers. "New England Journal of Medicine; 2004, 351(25): 2590-2598

Sun, J. Y., Gaidulis, L., Miller, M. M., Goto, R. M., Rodriguez, R., Forman, S. J., Senitzer, D. "Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. "Tissue Antigens; 2004, 64(4): 462-468

Trisal, V., Qian, D., Wagman, L. D. "Axillary recurrence in DCIS: Is axillary lymphadenectomy warranted?. "American Surgeon; 2004, 70(10): 876-880

Villacres, M. C., Longmate, J., Auge, C., Diamond, D. J. "Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. "Hum Immunol; 2004, 65(5): 476-485

Wang, J. J., Press, O. W., Lindgren, C. G., Greenberg, P., Riddell, S., Qian, X. J., Laugen, C., Raubitschek, A., Forman, S. J., Jensen, M. C. "Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8(+) cytotoxic T lymphocytes. "Molecular Therapy; 2004, 9(4): 577-586

Wang, J., Weiss, L. M., Hu, B., Chu, P., Zuppan, C., Felix, D., Rausei-Mills, V., Chase, D. R. "Usefulness of immunohistochemistry in delineating renal spindle cell tumours. A retrospective study of 31 cases. "Histopathology; 2004, 44(5): 462-471

Wang, Z. D., La Rosa, C., Maas, R., Ly, H., Brewer, J., Mekhoubad, S., Daftarian, P., Longmate, J., Britt, W. J., Diamond, D. J. "Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus. "Journal of Virology; 2004, 78(8): 3965-3976

Wang, Z. D., La Rosa, C., Mekhoubad, S., Lacey, S. F., Villacres, M. C., Markel, S., Longmate, J., Ellenhorn, J. D. I., Siliciano, R. F., Buck, C., Britt, W. J., Diamond, D. J. "Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. "Blood; 2004, 104(3): 847-856

Yen, Y., Chu, P. G., Feng, W. "Parathyroid hormone-related hypercalcemia in cholangiocarcinoma. "Journal of Clinical Oncology; 2004, 22(11): 2244-2245

Grant, M, Cooke, L, Bhatia, S, Forman, S "Discharge and unscheduled readmissions of adult hematopoietic cell transplant patients: Implications for developing nursing interventions.. "Oncology Nursing Forum; 2004, 32(1): E1-8

Nakamura, R., Battiwalla, M., Solomon, S., Follmann, D., Chakrabarti, S., Cortez, K., Hensel, N., Childs, R., Barrett, A. J. "Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. "Biology of Blood & Marrow Transplantation; 2004, 10(1): 49-57

Hueber, W., Zeng, D., Strober, S., Utz, P. J. "Interferon-alpha-inducible proteins are novel autoantigens in murine lupus. "Arthritis & Rheumatism; 2004, 50(10): 3239-49

Hueber, W., Zeng, D., Sharpe, O., Robinson, W., Strober, S., Utz, P. J. "Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice. "European Journal of Immunology; 2004, 34(6): 1654-62

Zeng, D., Lan, F., Hoffmann, P., Strober, S. "Suppression of graft-versus-host disease by naturally occurring regulatory T cells. "Transplantation; 2004, 77(1 Suppl): S9-S11

Lacey, S. F., Diamond, D. J., Zaia, Y. A. "Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants. "Biology of Blood and Marrow Transplantation; 2004, 10(7): 433-447

Bhatia, R., McGlave, P. B. "Autologous hematopoietic cell transplantation for chronic myelogenous leukemia. "Hematology-Oncology Clinics of North America; 2004, 18(3): 715-+

Ramaraj, P., Singh, H., Niu, N., Chu, S., Holtz, M., Yee, J. K., Bhatia, R. "Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. "Cancer Research; 2004, 64(15): 5322-5331

Alvarnas, J. C., Forman, S. J. "Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled. "Oncology (Williston Park); 2004, 18(7): 867-76; discussion

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.